Miklos Diossy

10PUBLICATIONS
60CO-AUTHORS
Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Sep 28, 2026
Identification of an ERCC2 Mutation-Associated Mutational Signature of Nucleotide Excision Repair Deficiency in Targeted Panel Sequencing Data.

|Feb 13, 2026
A Phase II Trial of Niraparib in Patients with Advanced Pancreatic Cancer Harboring Pathogenic Variants in ATM, BRCA1, BRCA2, PALB2, and CHEK2.

Brandon M Huffman, Miklos Diossy, Matthew B Yurgelun

|Sep 18, 2024
Frequent CHD1 deletions in prostate cancers of African American men is associated with rapid disease progression.

Miklos Diossy, Viktoria Tisza, Hua Li

|Apr 22, 2024
Increased frequency of CHD1 deletions in prostate cancers of African American men is associated with rapid disease progression without inducing homologous recombination deficiency.

Zoltan Szallasi, Miklos Diossy, Viktoria Tisza

|Jan 26, 2022
DNA Repair Pathways and Their Association With Lethal Prostate Cancer in African American and European American Men.

Anna Plym, Miklós Dióssy, Zoltan Szallasi

|Aug 12, 2021
Comparative Assessment of Diagnostic Homologous Recombination Deficiency-Associated Mutational Signatures in Ovarian Cancer.

Zsofia Sztupinszki, Miklos Diossy, Judit Borcsok

Pageof 2

Frequent Collaborators

8 joint publications

Judit Borcsok

7 joint publications

Zoltan Szallasi

4 joint publications

Zsofia Sztupinszki

4 joint publications

Istvan Csabai